Quality and Safety
The Integrated Healthcare Association, a statewide-based leadership group that promotes quality improvement, accountability and affordability of healthcare in California, has named its top 45 performing physician organizations for 2009, based on the IHA statewide Pay for Performance program measures.
The Centers for Medicare & Medicaid Services has awarded $13.7 million to six states to design background check programs for jobs involving direct patient care.
An important report has been released by the Government Accountability Office (GAO) pertaining to GPOs. It reaffirms what many of us have been saying for years now - that GPOs help unite a fragmented healthcare system.
Hundreds of healthcare human resources executives braved the stifling heat and swarms of Pittsburgh Steelers football fans descending upon Tampa Bay this weekend to attend the 46th annual conference and exposition for the American Society for Healthcare Human Resources Administration.
The patient mortality rate at Pennsylvania hospitals decreased significantly from 2002 through 2009, although the readmission rate increased considerably, according to the state's annual Hospital Performance Report.
In the early '70s, '80s and '90s we worked on a concept similar to accountable care organizations (ACOs) in California. We tried to establish a program that would cover risk for our patients' care with a lot of enthusiasm and effort. But unfortunately, we had very little success.
Hospitals can support patient-centered medical homes by linking them with affiliated physicians and offering health information technology, staff and management expertise, according to a report released Wednesday by the American Hospital Association.
Accredited hospitals in the United States are providing higher-quality, evidence-based care for heart attacks, pneumonia, surgical care and children's asthma, according to a new report by The Joint Commission.
The American College of Physicians has released a policy paper in support of increased healthcare transparency.
Forest Pharmaceuticals has agreed to pay more than $300 million, including $164 million in criminal penalties, for charges involving distribution of an unapproved new drug, distribution of a misbranded drug and obstruction of an FDA inspection.